XBiotech partners with BioBridge to develop plasma-based Covid-19 therapy
US biopharmaceutical company XBiotech has partnered with BioBridge Global to develop potential plasma-based Covid-19 therapy using natural antibodies from the convalescent plasma of recovered patients. ... Read More
Janssen to acquire skin disease drug candidate bermekimab from XBiotech
Janssen Biotech acquisition of bermekimab: Janssen Biotech, a Janssen Pharmaceutical Company of Johnson & Johnson, has agreed to acquire all rights to bermekimab, an investigational ... Read More